Quarterly report · Q1
7915.TEDINET S100TD9Q
Period2024-01-01 → 2024-03-31
Filed2024-05-10
StandardIFRS
ConsolidatedYes
Data checks10 of 10 passed
Key figures · 40
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | ¥1.3bn | 2024-01-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | −¥671m | 2023-01-01 → 2023-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥1.7bn | 2024-01-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥2.8bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | −¥791m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥1.2bn | 2024-01-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥3.0bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | −¥784m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥1.2bn | 2024-01-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Net income | −¥792m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥236.2bn | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥217.9bn | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥223.8bn | at 2023-03-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥122.3bn | at 2024-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥107.0bn | at 2023-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥113.9bn | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥110.9bn | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥108.7bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥111.5bn | at 2022-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥113.7bn | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥110.9bn | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥108.7bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥34.0bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥37.9bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥46.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥5.2bn | 2024-01-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥1.5bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | −¥2.4bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥10.6bn | 2024-01-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥8.0bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥3.0bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥119m | 2024-01-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥12.6bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥3.1bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥25.65 | 2024-01-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-61.13 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥-15.97 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS |
| Equity ratio | 48.1% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 50.9% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 48.6% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 14
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-03-31 | −¥268m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-03-31 | −¥420m |
| jpcrp040300-q1r_E00703-000Devicesreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥432m |
| jpcrp040300-q1r_E00703-000Industrial Materialsreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥1.1bn |
| jpcrp040300-q1r_E00703-000Medical Technologiesreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥408m |
| —segment total | segment profit | 2024-01-01 → 2024-03-31 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-03-31 | ¥1.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-03-31 | −¥208m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | −¥610m |
| jpcrp040300-q1r_E00703-000Devicesreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥868m |
| jpcrp040300-q1r_E00703-000Industrial Materialsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥519m |
| jpcrp040300-q1r_E00703-000Medical Technologiesreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥496m |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | ¥147m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-03-31 | −¥60m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 770
| Item | Context | Value | Unit |
|---|---|---|---|
| Finance income IFRS | Prior1YTDDuration_jpcrp040300-q1r_E00703-000IndustrialMaterialsReportableSegmentMember | － | JPY |
| Finance income IFRS | Prior1YTDDuration_jpcrp040300-q1r_E00703-000DevicesReportableSegmentMember | － | JPY |
| Finance income IFRS | Prior1YTDDuration_jpcrp040300-q1r_E00703-000MedicalTechnologiesReportableSegmentMember | － | JPY |
| Finance income IFRS | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Finance income IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Finance income IFRS | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Finance income IFRS | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Finance income IFRS | Prior1YTDDuration | 318000000 | JPY |
| Finance costs IFRS | Prior1YTDDuration_jpcrp040300-q1r_E00703-000IndustrialMaterialsReportableSegmentMember | － | JPY |
| Finance costs IFRS | Prior1YTDDuration_jpcrp040300-q1r_E00703-000DevicesReportableSegmentMember | － | JPY |
| Finance costs IFRS | Prior1YTDDuration_jpcrp040300-q1r_E00703-000MedicalTechnologiesReportableSegmentMember | － | JPY |
| Finance costs IFRS | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Finance costs IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Finance costs IFRS | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Finance costs IFRS | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Finance costs IFRS | Prior1YTDDuration | 439000000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration_jpcrp040300-q1r_E00703-000IndustrialMaterialsReportableSegmentMember | － | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration_jpcrp040300-q1r_E00703-000DevicesReportableSegmentMember | － | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration_jpcrp040300-q1r_E00703-000MedicalTechnologiesReportableSegmentMember | － | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | -791000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00703-000IndustrialMaterialsReportableSegmentMember | 17841000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00703-000DevicesReportableSegmentMember | 16569000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00703-000MedicalTechnologiesReportableSegmentMember | 10069000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_ReportableSegmentsMember | 44480000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2238000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 46719000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Sales to external customers IFRS | CurrentYTDDuration | 46719000000 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00703-000IndustrialMaterialsReportableSegmentMember | 0 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00703-000DevicesReportableSegmentMember | -0 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00703-000MedicalTechnologiesReportableSegmentMember | － | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_ReportableSegmentsMember | -0 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 232000000 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 232000000 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_ReconcilingItemsMember | -232000000 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration | － | JPY |
| Net sales IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00703-000IndustrialMaterialsReportableSegmentMember | 17841000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00703-000DevicesReportableSegmentMember | 16569000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00703-000MedicalTechnologiesReportableSegmentMember | 10069000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_ReportableSegmentsMember | 44480000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2470000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 46951000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_ReconcilingItemsMember | -232000000 | JPY |
| Net sales IFRS | CurrentYTDDuration | 46719000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00703-000IndustrialMaterialsReportableSegmentMember | 1149000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00703-000DevicesReportableSegmentMember | 432000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |